Skip to content
葆元
rfc8rr02gd78
Home
About
Introduction
Mission & Vision
Values
Management
News
Key Product
Partnering
Job Opportunities
Contact
中文 (中国)
Search for:
Previous
Next
Management
Junyuan Wang,
Ph.D.
Co-Founder
CEO
Readme
Bing Yan,
M.D., MBA
Co-Founder
Chief Medical Officer
Readme
Lihua Zheng,
J.D., Ph.D.
Co-Founder
Chief Business Officer
Readme
News
Research results of AnHeart’s new-generation ROS1/NTRK inhibitor AB-106 published in Nature Communications
AnHeart Therapeutics Won the 2019 Sullivan China New Economy
AnHeart Therapeutics completed 100 million Chinese Yuan Series A round of financing; new anti-cancer drugs to enter China's clinical trials
Daiichi Sankyo Out-Licenses ROS1/NTRK Inhibitor DS-6051 to AnHeart Therapeutics
Home
About
Introduction
Mission & Vision
Values
Management
News
Key Product
Partnering
Job Opportunities
Contact
中文 (中国)
Search for:
Scroll to top
